Our Research Publications
Updated August 2025
| Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
|---|---|---|---|---|---|---|
| Drug-induced immune haemolytic anaemias | Branch DR | 2019 | ISBT Sci Ser | View Drug-induced immune haemolytic anaemias | Researchers | Basic research |
| Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department | Ramos JG, Zeller MP | 2019 | Hematology Am Soc Hematol Educ Program | View Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
| Label-Free Analysis of Red Blood Cell Storage Lesions Using Imaging Flow Cytometry | Pinto RN, Sebastian JA, Parsons MJ, Chang TC, Turner TR, Acker JP, Kolios MC | 2019 | Cytom Part A | View Label-Free Analysis of Red Blood Cell Storage Lesions Using Imaging Flow Cytometry | Researchers | New or improved product or process |
| Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors | Al-Riyami AZ, Al-Marhoobi A, Al-Hosni S, Al Mahrooqi S, Schmidt M, O'Brien SF, Al-Khabori M | 2019 | Oman Med J | View Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors | Researchers | Clinical research |
| Système Rhésus : l’anticorps anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-Cw | Health care providers | Benchmarking and standard setting |
| Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Blake J, Clarke G | 2019 | Blood.ca website | View Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Researchers | Clinical research |
| A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Ivetic N, Arnold D, Smith J, Huynh A, Kelton J, Nazy I | 2019 | Platelets | View A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Researchers | Basic research |
| Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach | Lieberman L, Greinacher A, Murphy M, Bussel J, Bakchoul T, Corke S, Killie M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker J, Hume H, Massey E, Kaplan C, Arnold D, Baidya S, Ryan G, Savoia H, Landry D, Shehata N | 2019 | Br J Haematol | View Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach | Health care providers | Benchmarking and standard setting |
| Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2019 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
| Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries | Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, Germini F, for the Data Demographics Committee of the World Federation of Hemophilia | 2019 | Ann Intern Med | View Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries | Researchers | Clinical research |
| Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? | Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, Connors JM, Iba T, Warkentin TE | 2019 | J Thromb Haemost | View Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? | Researchers | Clinical research |
| Système Kell : l’anticorps anti-Kpa | Peng S, Meunier D | 2019 | Blood.ca website | View Système Kell : l’anticorps anti-Kpa | Health care providers | Benchmarking and standard setting |
| Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee | Cohn CS, Allen ES, Cushing MM, Dunbar NM, Friedman DF, Goel R, Harm SK, Heddle N, Hopkins CK, Klapper E, Perumbeti A, Ramsey G, Raval JS, Schwartz J, Shaz BH, Spinella PC, Pagano MB | 2019 | Transfusion | View Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee | Researchers | Clinical research |
| Modulating the T Lymphocyte Immune Response via Secretome Produced miRNA: From Tolerance Induction to the Enhancement of the Anticancer Response | Scott M, Wang D, Toyofuku W, Yang X | 2019 | Cells of the Immune System | View Modulating the T Lymphocyte Immune Response via Secretome Produced miRNA: From Tolerance Induction to the Enhancement of the Anticancer Response | Researchers | Basic research |
| A retrospective study of the added value of parallel titers compared with serial titers | Lin Y, Cohen R, Buckstein J, Callum J, Lieberman L | 2019 | Transfusion | View A retrospective study of the added value of parallel titers compared with serial titers | Health care providers | Clinical research |
| Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Scott AN, Buchan SA, Kwong JC, Drews SJ, Simmonds KA, Svenson LW | 2019 | BMJ Open | View Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Researchers | Clinical research |
| Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis | Murphy MSQ, Tinmouth A, Goldman M, Chasse M, Colas JA, Saidenberg E, Shehata N, Fergusson D, Forster AJ, Wilson K | 2019 | Transfusion | View Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis | Researchers | Clinical research |
| Syndrome respiratoire aigu post-transfusionnel (TRALI) | Petraszko T | 2019 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Researchers | Clinical research |
| Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia | Vollenberg R, Jouni R, Norris PAA, Burg-Roderfeld M, Cooper N, Rummel MJ, Bein G, Marini I, Bayat B, Burack R, Lazarus AH, Bakchoul T, Sachs UJ | 2019 | Haematologica | View Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia | Researchers | Basic research |
| MNS System: Anti-M | Clarke G, Côté J, Lane D | 2019 | Blood.ca website | View MNS System: Anti-M | Health care providers | Benchmarking and standard setting |
| ResearchUnit: Fighting inflammation with inflammation | Lazarus A | 2019 | Blood.ca website | View ResearchUnit: Fighting inflammation with inflammation | Researchers | Clinical research |
| Treating murine inflammatory diseases with an anti-erythrocyte antibody | Crow AR, Kapur R, Koernig S, Campbell IK, Jen C-C, Mott PJ, Marjoram D, Khan R, Kim M, Brasseit J, Cruz-Leal Y, Amash A, Kahlon S, Yougbare I, Ni H, Zuercher AW, Käsermann F, Semple JW, Lazarus AH | 2019 | Sci Transl Med | View Treating murine inflammatory diseases with an anti-erythrocyte antibody | Researchers | Basic research |
| Trombocitopenia Fetal Neonatal Aloimune: Informacao ao paciente | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Trombocitopenia Fetal Neonatal Aloimune: Informacao ao paciente | Other | Other |
| Heparin-induced thrombocytopenia (Chap. 26). | Warkentin TE | 2019 | Consultative Hemostasis and Thrombosis, Fourth Edition | View Heparin-induced thrombocytopenia (Chap. 26). | Other | Benchmarking and standard setting |
| Bonnes pratiques en matière de transfusion de plaquettes | Romans R | 2019 | Blood.ca website | View Bonnes pratiques en matière de transfusion de plaquettes | Health care providers | Benchmarking and standard setting |
| Platelet clinical best practices | Romans R | 2019 | Blood.ca website | View Platelet clinical best practices | Health care providers | Benchmarking and standard setting |
| Surveillance Report 2018 | O'Brien S | 2019 | Blood.ca website | View Surveillance Report 2018 | Health care providers | Benchmarking and standard setting |
| Thrombopénie néonatale par allo-immunisation fÅ“tomaternelle: Brochure d'information | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Thrombopénie néonatale par allo-immunisation fÅ“tomaternelle: Brochure d'information | Other | Other |
| ResearchUnit: Modeling risk to ensure safety when considering changes to blood testing | O'Brien S | 2019 | Blood.ca website | View ResearchUnit: Modeling risk to ensure safety when considering changes to blood testing | Researchers | Basic research |
| Variations in RBC and frozen plasma utilization rates across 62 Ontario community hospitals | Qiang JK, Thompson T, Callum J, Pinkerton P, Lin Y | 2019 | Transfusion | View Variations in RBC and frozen plasma utilization rates across 62 Ontario community hospitals | Health care providers | Clinical research |
| The association between platelet transfusions and mortality in patients with critical illness | Ning S, Liu Y, Barty R, Cook R, Rochwerg B, Iorio A, Warkentin TE, Heddle NM, Arnold DM | 2019 | Transfusion | View The association between platelet transfusions and mortality in patients with critical illness | Researchers | Clinical research |
| Diego System: Anti-Dia | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Dia | Health care providers | Benchmarking and standard setting |
| The impact of red blood cell manufacturing variables on bacterial growth dynamics: a pilot study | Ramirez-Arcos S, Kou Y, Cayer M-P, De Grandmont M-J, Girard M, Cloutier M | 2019 | Vox Sang | View The impact of red blood cell manufacturing variables on bacterial growth dynamics: a pilot study | Researchers | Basic research |
| Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Pasha R, Halpenny M, Pineault N | 2019 | Vox Sang | View Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Researchers | New or improved product or process |
| Immunotherapy: the good, the bad, the ugly, and the really ugly | Branch DR | 2019 | Transfusion | View Immunotherapy: the good, the bad, the ugly, and the really ugly | Researchers | Clinical research |
| An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia | Eekels JJM, Althaus K, Bakchoul T, Kroll H, Kiefel V, Nazy I, Lee LS, Sachs U, Warkentin TE, Greinacher A | 2019 | J Thromb Haemost | View An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia | Researchers | New or improved product or process |
| Anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Anti-Lewis | Health care providers | Clinical research |
| Laboratory diagnosis of heparin-induced thrombocytopenia | Warkentin TE | 2019 | Int J Lab Hematol | View Laboratory diagnosis of heparin-induced thrombocytopenia | Health care providers | Clinical research |
| Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Atreya C, Glynn S, Busch M, Kleinman S, Snyder E, Rutter S, AuBuchon J, Flegel W, Reeve D, Devine D, Cohn C, Custer B, Goodrich R, Benjamin RJ, Razatos A, Cancelas J, Wagner S, Maclean M, Gelderman M, Cap A, Ness P | 2019 | Transfusion | View Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Researchers | New or improved product or process |
| Système Rhésus : l’anticorps anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-V | Health care providers | Benchmarking and standard setting |
| How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry | Patriquin CJ, Kiss T, Caplan S, Chin-Yee I, Grewal K, Grossman J, Larratt L, Marceau D, Nevill T, Sutherland DR, Wells RA, Leber B | 2019 | Eur J Haematol | View How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry | Researchers | Clinical research |
| Assessing the Threat: Public Concern | Wiles A, Bennett JL, Devine D | 2019 | Blood Safety : A Guide to Monitoring and Responding to Potential New Threats | View Assessing the Threat: Public Concern | Other | Benchmarking and standard setting |
| Evaluating the Clinical Effect of Female Blood Donors of Child-Bearing Age on Maternal and Neonatal Outcomes: A Cohort Study | Chassé M, Tinmouth A, Goldman M, O'Brien SF, Hawken S, Murphy MSQ, Walker M, Sprague AE, Wilson K, van Walraven C, Fergusson DA | 2019 | Transfus Med Rev | View Evaluating the Clinical Effect of Female Blood Donors of Child-Bearing Age on Maternal and Neonatal Outcomes: A Cohort Study | Researchers | Clinical research |
| Postnatal intervention for the treatment of FNAIT: a systematic review | Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H, On behalf of the International Collaboration for Transfusion Medicine Guidelines (ICTMG) | 2019 | J Perinatol | View Postnatal intervention for the treatment of FNAIT: a systematic review | Health care providers | Clinical research |
| Système Lewis : les anticorps anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Système Lewis : les anticorps anti-Lewis | Health care providers | Benchmarking and standard setting |
| Vein to Vein: A Summary of the Blood System in Canada | Chargé S | 2019 | Clinical Guide to Transfusion | View Vein to Vein: A Summary of the Blood System in Canada | Health care providers | Benchmarking and standard setting |
| Contextual factors influencing donor recruitment and cord blood collection: perspectives of frontline staff of the Canadian Blood Services' Cord Blood Bank | Haw J, Polzer J, Devine DV | 2019 | Transfusion | View Contextual factors influencing donor recruitment and cord blood collection: perspectives of frontline staff of the Canadian Blood Services' Cord Blood Bank | Researchers | New or improved product or process |
| Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation | Iba T, Levy JH, Raj A, Warkentin TE | 2019 | J Clin Med | View Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation | Health care providers | Clinical research |
| Cryoprotection of platelets by grafted polymers | Scott M, Nakane N, Maurer-Spurej E | 2019 | Cryopreservation - Current Advances and Evaluations | View Cryoprotection of platelets by grafted polymers | Researchers | Basic research |
| HIV Risk Factors | Goldman M | 2019 | Screening Blood Donors with the Donor History Questionnaire | View HIV Risk Factors | Blood operators | Benchmarking and standard setting |